Azie, Nkechi

Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008

Pfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 396

The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012

Azie, N., Neofytos, D., Pfaller, M., Meier-Kriesche, H.-U., Quan, S.-P., & Horn, D. (2012) · Diagnostic Microbiology and Infectious Disease

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 222

Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study

Kontoyiannis, D. P., Yang, H., Song, J., Kelkar, S. S., Yang, X., Azie, N., Harrington, R., Fan, A., Lee, E., & Spalding, J. R. (2016) · BMC Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 132

Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance® registry

Horn, D. L., Freifeld, A. G., Schuster, M. G., Azie, N. E., Franks, B., & Kauffman, C. A. (2014) · Mycoses

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 83

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

Schwebke, J. R., Sobel, R., Gersten, J. K., Sussman, S. A., Lederman, S. N., Jacobs, M. A., Chappell, B. T., Weinstein, D. L., Moffett, A. H., Azie, N. E., et al. (2022) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 82

Oral Ibrexafungerp: An Investigational Agent for the Treatment of Vulvovaginal Candidiasis

Azie, N., Angulo, D., Dehn, B., & Sobel, J. D. (2020) · Expert Opinion on Investigational Drugs

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 46